← Back to Vaccine Database

RSV LID cp ΔM2-2

Live attenuated vaccine · VDDBV0658

Target & Classification

RSVRespiratory syncytial virus
Live attenuated vaccine
Respiratory syncytial virus
Phase 1

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials2

NCT IDPhaseDisease / Condition
NCT02948127 Phase 1Respiratory syncytial virus
NCT02890381 Phase 1Respiratory syncytial virus